The application of the same analysis using the Kaplan-Meier method and the log-rank test to IL-36γ, detected significant differences in the survival curves of CRC patients between IL-36γhigh and IL-36γlow patients only in patients with no lymph node metastasis (P = 0.008, Fig. 4d), in patients who were TNM I-II (P = 0.002, Fig. 4f), and in patients with a left-sided CRC (P = 0.05, Fig. 4h). This evidence concerns the gene IL36G and colorectal carcinoma.